Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

ESMO 21st World Congress on Gastrointestinal Cancer /
Immunotherapy with radiation in metastatic pancreatic and colorectal adenocarcinoma

3rd - 7th Jul 2019

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 15.07.19
Views: 689
Rating:

Dr Aparna Parikh - Massachusetts General Hospital Cancer Center, Boston, USA

Dr Aparna Parikh speaks to ecancer at ESMO 21st World Congress on Gastrointestinal Cancer about the use of immunotherapy and radiation in combination in metastatic pancreatic and colorectal adenocarcinoma.

She explains that phase 2 study used ipilimumab and nivolumab with radiation to stimulate an immuno response in a select amount of patients, which are exciting results considering immunotherapy alone has not generally been shown to be effective in treating these cancers.

Dr Parikh explains that the next steps are to determine the best timing and dosage of radiation in future studies, as well as becoming more adept at managing toxicity.

 

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation